ArrowMark Colorado Holdings’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

ArrowMark Colorado Holdings’s Portfolio RVLP Stock Details RVLP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,506,002	Closed	-$844K	–	331
2023 Q2	$844K	Sell	1,506,002 -116,998	-7%	-$103K	0.01%	258
2023 Q1	$1.85M	Hold	1,623,000	–	–	0.02%	233
2022 Q4	$1.82M	Hold	1,623,000	–	–	0.02%	235
2022 Q3	$3.41M	Hold	1,623,000	–	–	0.04%	233
2022 Q2	$2.21M	Hold	1,623,000	–	–	0.03%	246
2022 Q1	$2.74M	Buy	1,623,000 +623,000	+62%	+$891K	0.02%	261
2021 Q4	$1.08M	Buy	+1,000,000	New	+$1.62M	0.01%	291

Other funds holding RVLP

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

TAM

Titleist Asset Management San Antonio, Texas $1.49B AUM 22.27% 1-Year Est. Return

ArrowMark Colorado Holdings's RVLP Position: Q3 2023 in Review

ArrowMark Colorado Holdings sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2023, closing a stake of 1,506,002 shares — an estimated $844K sold.

ArrowMark Colorado Holdings first reported a position in RVLP in Q4 2021 and held it in 7 quarters. The position peaked at $3.41M in Q3 2022. 32 funds tracked by Wall St. Rank hold RVLP as of Q3 2023.

ArrowMark Colorado Holdings reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2023 after selling out during the quarter.
ArrowMark Colorado Holdings sold 1,506,002 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2023, an estimated $844K.
ArrowMark Colorado Holdings first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2021 and held it in 7 quarters.
ArrowMark Colorado Holdings's RVL Pharmaceuticals plc Ordinary Shares position peaked at $3.41M in Q3 2022.
32 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2023.

Based on ArrowMark Colorado Holdings's 13F filing for Q3 2023, filed 14 Nov 2023.